Download full-text PDF

Source
http://dx.doi.org/10.1007/s11695-021-05391-0DOI Listing

Publication Analysis

Top Keywords

cases euglycemic
4
euglycemic diabetic
4
diabetic ketoacidosis
4
ketoacidosis bariatric
4
bariatric surgery
4
surgery associated
4
associated sodium-glucose
4
sodium-glucose cotransporter-2
4
cotransporter-2 inhibitor
4
cases
1

Similar Publications

Development of Nonketotic Hyperglycemia Requiring High-Dose Insulin After Supratherapeutic Amlodipine Ingestion.

AACE Clin Case Rep

September 2024

Department of Medicine, Suburban Hospital, Johns Hopkins Medicine, Bethesda, Maryland.

Background/objective: Calcium channel blockers, when taken in overdose quantities, can cause hyperglycemia requiring so-called hyperinsulinemic-euglycemic therapy. The objective of this report was to describe a patient with calcium channel blocker toxicity resulting from overdose of amlodipine.

Case Report: A 74-year-old man presented with a fall and loss of consciousness.

View Article and Find Full Text PDF

Background/objectives: Pregnant and postpartum women have a higher risk for developing severe Covid-19 and other clinical and obstetric complications. This study aims to evaluate the frequency of metabolic acidosis with elevated anion gap and describe a case series of euglycemic ketoacidosis (EKA) in pregnant and postpartum women with severe confirmed or suspected Covid-19.

Materials And Methods: Observational retrospective study carried in a reference intensive care unit from May 2020 to June 2022.

View Article and Find Full Text PDF

Background: The development of minimally invasive continuous glucose monitoring systems (CGMs) has transformed diabetes management. CGMs have shown clinical significance by improving time in the euglycemic range, decreasing rates of hypoglycemia, and improving HbA1c. In Rwanda, CGMs are currently not in routine use, and no clinical studies of CGM use were identified in the literature.

View Article and Find Full Text PDF

Telogen effluvium can be triggered by physical exhaustion, drug use, and emotional stress. However, in approximately 33% of cases, the triggers are unknown. Telogen effluvium can develop two to three months after exposure to triggers and improve three to six months after trigger removal.

View Article and Find Full Text PDF

Euglycemic ketoacidosis is an acute, life-threatening emergency that is characterized by euglycemia, metabolic acidosis, and ketonemia. It is a well-recognized adverse event in diabetic patients taking sodium-glucose cotransporter-2 inhibitor (SGLT-2 inhibitor). However, there is limited data on SGLT-2 inhibitor-related euglycemic ketoacidosis in non-diabetic patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!